Search
Menu
Home
HTB
2019
September
September 2019
Contents
Editorial
HTB 30 September 2019 online
Conference reports
10th IAS Conference on HIV Science (IAS 2019): final reports
Low rates of pregnancy with three methods of contraception in the ECHO trial
Other pregnancy studies IAS 2019
Antiretrovirals
Scotland approves dual therapy with dolutegravir/lamivudine (Dovato)
FDA expands indication for doravirine in the US as switch option
Treatment access
UK HIV organisations call for urgent review of crisis in sexual health funding
Guidelines
WHO update PrEP guidelines to include event-based dosing
UK issue joint guidelines on HIV discrimination in tattoo and beauty salons
Side effects
Greater weight gain with INSTI-based than non-INSTI-based ART among women in US cohort
Other news
UK is one of four EU countries to lose measles elimination status
On the web
Women and HIV research: free educational webcasts
PDFs
30 September 2019 vol 20 no 11
HTB RSS
Early access
Gates Foundation commits to providing lenacapavir as PrEP next year
3 June 2025
All early access reports
Current issues
June 2025
May 2025
April 2025
Back issues
Special report
Latest news on the US crisis and its impact on global health
30 May 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate